Skip to main content
. 2018 Oct 29;10(10):e3510. doi: 10.7759/cureus.3510

Table 1. Treatment planning objectives used by dosimetrist to generate the treatment plan for this patient. The lower number in the fifth column indicates higher priority.

Target and Critical Normal Tissue Constraints
Structure Name DVH Objective Evaluator Variation Acceptable Priority
PTVeval_BREAST D95%[Gy] ≥ 40.4 ≥ 38.3 1
PTVeval_BREAST V90%[%] ≥​​​​​​​ 99 ≥​​​​​​​ 98 2
PTVeval_BREAST V105%[%] ≤​​​​​​​ 10 ≤ ​​​​​​​ 15 2
PTVeval_BREAST Max[%] ≤ ​​​​​​​ 107 ≤ ​​​​​​​ 110 1
BREAST_CONTRA D5%[Gy] ≤ ​​​​​​​ 2 ≤ ​​​​​​​ 3 3
LUNG_IPSI V20Gy[%] ≤ ​​​​​​​ 15 ≤ ​​​​​​​ 20 2
LUNG_IPSI V5Gy[%] ≤ ​​​​​​​ 50 ≤ ​​​​​​​ 55 2
LUNG_CONTRA V5Gy[%] ≤ ​​​​​​​ 10 ≤ ​​​​​​​ 15 3
HEART V20Gy[%] ≤ ​​​​​​​ 2 ≤ ​​​​​​​ 5 2
HEART Mean[Gy] ≤ ​​​​​​​ 3 ≤ ​​​​​​​ 4 2